logo
logo

Megalabs Acquires Majority Interest and Control of DS Laboratories to enhance position in the global dermatology market

May 31, 2024•about 1 year ago

Acquiring Company

Megalabs

Acquired Company

DS Laboratories

CanelonesMiamiPharmaceuticalBiotechnologyHealth CareManufacturingBeautyLifestyleFashionHealth Care

Description

Megalabs, a leading pharmaceutical company, has acquired majority interest and control of DS Laboratories, a leading dermatology company focused on science-backed hair care across 50+ countries. This strategic move enhances Megalabs' position in the global dermatology market and the US.

Company Information

Company

Megalabs

Location

Canelones, Canelones, Uruguay

About

Megalabs is a leading pharmaceutical company committed to providing healthcare professionals and consumers with affordable therapeutic solutions for a healthier and more fulfilling life. The company is present in 20 countries with more than 8,500 collaborators and offers more than 1,800 products that cross all therapeutic areas. Its continuous growth is supported by 18 production plants, a highly diversified portfolio with more than 1,800 products, and seven R&D centers. Megalabs is a forward-looking company with an established reputation as one of the leading pharmaceutical players in the Americas.

DealWatch™ Score

85
High M&A Activity

M&A Opportunity Analysis

Get personalized insights on M&A opportunities

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

Gianclaudio hidden

hidden
hidden

Mathias hidden

hidden
hidden